The State of Connecticut Attorney General’s Office Press Release announced a landmark $25.1 million agreement with drug maker Eli Lilly and Company for allegedly marketing its antipsychotic drug Zyprexa for unapproved uses, and concealing the drug’s serious side effects, for more than a decade.  The Connecticut AG’s office sued Eli Lilly last year for corrupting…

Continue reading →